Content area

|
|

Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Forfatter(e)
Marie Møller Christensen1, Tina Jorsal1, Lars Peter Skat Naver2, Tina Vilsbøll1 & Filip Krag Knop1 1) Center for Diabetesforskning, Gentofte Hospital 2) Privathospitalet Møn Ugeskr Læger 2017;179:V03170198
Reference: 
Ugeskr Læger 2017;179:V03170198
Blad nummer: 
Sidetal: 
2-5
Gastric aspiration therapy is a possible alternative to treatment of obesity
Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate about 30% of an ingested meal through a draining system via a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the FDA, and it induces weight loss comparable to bariatric surgery but with a lower risk. Few clinical studies about the efficacy/safety of AspireAssist have been carried out, so further intervention studies evaluating acute and long-term effects are warranted.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Julius Vindbjerg Nissen | 14/08
1 Kommentar
af Ulrich Fredberg | 14/08
1 Kommentar
af Karen Flink Konstantin-Hansen | 13/08
3 kommentarer
af Susanne Mejlby Nielsen | 06/08
4 kommentarer
af Gunvor Kramshøj Larsen | 04/08
28 kommentarer
af Olaf Bjarne Paulson | 03/08
1 Kommentar
af Hanne Hulgaard | 02/08
4 kommentarer
af Christian Stefan Legind | 28/07
1 Kommentar
af Connie Lærkholm Hansen | 23/07
1 Kommentar